Highvista-Strategies

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "AKRO",
  "KNSA",
  "NUVL",
  "AXSM",
  "ASND",
  "EWTX",
  "CNTA",
  "SE",
  "ALKS",
  "INSM",
  "RVMD",
  "ARGX",
  "RXO",
  "PBR-A",
  "AAL",
  "AMED",
  "RBC",
  "QSR",
  "ACN",
  "MDGL",
  "MMM",
  "BABA",
  "APLS",
  "MAGN",
  "ABVX",
  "AVGO",
  "AGX",
  "DVAX",
  "PFSI",
  "OFIX",
  "SWTX",
  "ARVN",
  "OLMA",
  "GPCR",
  "CATX",
  "MIRM",
  "TYRA",
  "LQDA",
  "KYMR",
  "PHVS",
  "KROS",
  "JANX",
  "IBN",
  "CAAP",
  "INTU",
  "GERN",
  "SRRK",
  "SYRE",
  "APGE",
  "GH",
  "ACI",
  "HUBS",
  "BKNG",
  "META",
  "KALV",
  null,
  "PWR",
  "MRVL",
  "MA",
  "QXO",
  "MSFT",
  "CORZ",
  "DUOL",
  "HES",
  "NU",
  "ZYME",
  "ANSS",
  "PGR",
  "NVDA",
  "HPE",
  "GEHC",
  "STX",
  "SNPS",
  "TKO",
  "UAL",
  "PTGX",
  "NATL",
  "EYE",
  "RNA",
  "AGIO",
  "RCL",
  "PRAX",
  "PLRX",
  "RYTM",
  "TLN",
  "MLTX",
  "SLNO",
  "LKQ",
  "ACLX",
  "COGT",
  "DYN",
  "TSM",
  "BN.TO",
  "SRPT",
  "APH",
  "NTRA",
  "WVE",
  "ROIV",
  "ERAS",
  "ELVN",
  "BZ",
  "AMZN",
  "HDB",
  "VRNA",
  "V",
  "VRDN",
  "WDC",
  "WDAY",
  "XOMA",
  "XENE",
  "XPO",
  "PTC",
  "XNCR",
  "VERA",
  "JD",
  "JNPR",
  "MTZ",
  "ON",
  "RARE",
  "TCOM",
  "CRM",
  "IMVT",
  "GEV",
  "PCVX",
  "BBD",
  "BHC",
  "BBIO",
  "CGON",
  "CIEN",
  "BVN",
  "CSCO",
  "CNX",
  "STZ",
  "CEG",
  "CRBP",
  "CPNG",
  "CRNX",
  "CRH",
  "CGEM",
  "CYTK",
  "DNTH",
  "DAL",
  "IRON",
  "ELV",
  "GOOG",
  "PM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 148
Total Value: 259519597
Accession Number: 0001172661-25-001991
Form Type: 13F-HR
CIK: highvista-strategies
Manager Name: Highvista-Strategies

Data Enrichment

99% identified

147 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

148 positions • $259.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 7 of 8

Sort by:

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

Shares:31.4K

Value:$569.4K

% of Portfolio:0.2% ($569.4K/$259.5M)

Accenture plc

ACN|G1151C101

Shares:1.8K

Value:$561.7K

% of Portfolio:0.2% ($561.7K/$259.5M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:39.0K

Value:$561.1K

% of Portfolio:0.2% ($561.1K/$259.5M)

CG Oncology, Inc.

CGON|156944100

Shares:22.3K

Value:$546.2K

% of Portfolio:0.2% ($546.2K/$259.5M)

Natera, Inc.

NTRA|632307104

Shares:3.9K

Value:$544.4K

% of Portfolio:0.2% ($544.4K/$259.5M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:52.1K

Value:$531.0K

% of Portfolio:0.2% ($531.0K/$259.5M)

Zymeworks Inc.

ZYME|98985Y108

Shares:41.6K

Value:$495.5K

% of Portfolio:0.2% ($495.5K/$259.5M)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

Shares:13.3K

Value:$482.6K

% of Portfolio:0.2% ($482.6K/$259.5M)

JD.com, Inc.

JD|47215P106

Shares:11.2K

Value:$459.8K

% of Portfolio:0.2% ($459.8K/$259.5M)

Wave Life Sciences Ltd.

WVE|Y95308105

Shares:53.4K

Value:$431.3K

% of Portfolio:0.2% ($431.3K/$259.5M)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:8.9K

Value:$402.8K

% of Portfolio:0.2% ($402.8K/$259.5M)

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

Shares:75.3K

Value:$399.8K

% of Portfolio:0.2% ($399.8K/$259.5M)

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:33.3K

Value:$384.3K

% of Portfolio:0.1% ($384.3K/$259.5M)

Pharvaris N.V.

PHVS|N69605108

Shares:22.8K

Value:$357.5K

% of Portfolio:0.1% ($357.5K/$259.5M)

Xencor Inc

XNCR|98401F105

Shares:31.9K

Value:$339.9K

% of Portfolio:0.1% ($339.9K/$259.5M)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:5.2K

Value:$332.6K

% of Portfolio:0.1% ($332.6K/$259.5M)

Disc Medicine, Inc.

IRON|254604101

Shares:6.5K

Value:$320.6K

% of Portfolio:0.1% ($320.6K/$259.5M)

Abivax S.A.

ABVX|00370M103

Shares:49.1K

Value:$306.6K

% of Portfolio:0.1% ($306.6K/$259.5M)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:17.6K

Value:$304.0K

% of Portfolio:0.1% ($304.0K/$259.5M)

Perspective Therapeutics, Inc.

CATX|46489V302

Shares:138.3K

Value:$294.7K

% of Portfolio:0.1% ($294.7K/$259.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Dianthus Therapeutics, Inc. /DE/(DNTHcusip252828108)	31.4K	QoQ 0.00% (-0) YoY NEW(+31.4K)	All Managers (Combined)	$569.4K	0.2% ($569.4K/$259.5M)	QoQ -16.78% (-$114.9K) YoY NEW(+$569.4K)
Accenture plc(ACNcusipG1151C101)	1.8K	QoQ NEW(+1.8K) YoY NEW(+1.8K)	All Managers (Combined)	$561.7K	0.2% ($561.7K/$259.5M)	QoQ NEW(+$561.7K) YoY NEW(+$561.7K)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	39.0K	QoQ -15.38% (-7.1K) YoY NEW(+39.0K)	All Managers (Combined)	$561.1K	0.2% ($561.1K/$259.5M)	QoQ -27.35% (-$211.3K) YoY NEW(+$561.1K)
CG Oncology, Inc.(CGONcusip156944100)	22.3K	QoQ 0.00% (-0) YoY NEW(+22.3K)	All Managers (Combined)	$546.2K	0.2% ($546.2K/$259.5M)	QoQ -14.60% (-$93.5K) YoY NEW(+$546.2K)
Natera, Inc.(NTRAcusip632307104)	3.9K	QoQ -20.25% (-978) YoY NEW(+3.9K)	All Managers (Combined)	$544.4K	0.2% ($544.4K/$259.5M)	QoQ -28.76% (-$219.8K) YoY NEW(+$544.4K)
Keros Therapeutics, Inc.(KROScusip492327101)	52.1K	QoQ 0.00% (-0) YoY +32.89% (-12.9K)	All Managers (Combined)	$531.0K	0.2% ($531.0K/$259.5M)	QoQ -35.62% (-$293.9K) YoY -79.54% (-$2.1M)
Zymeworks Inc.(ZYMEcusip98985Y108)	41.6K	QoQ NEW(+41.6K) YoY NEW(+41.6K)	All Managers (Combined)	$495.5K	0.2% ($495.5K/$259.5M)	QoQ NEW(+$495.5K) YoY NEW(+$495.5K)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	13.3K	QoQ NEW(+13.3K) YoY NEW(+13.3K)	All Managers (Combined)	$482.6K	0.2% ($482.6K/$259.5M)	QoQ NEW(+$482.6K) YoY NEW(+$482.6K)
JD.com, Inc.(JDcusip47215P106)	11.2K	QoQ +3.70% (+400) YoY -82.09% (-51.3K)	All Managers (Combined)	$459.8K	0.2% ($459.8K/$259.5M)	QoQ +23.00% (+$86.0K) YoY -73.12% (-$1.3M)
Wave Life Sciences Ltd.(WVEcusipY95308105)	53.4K	QoQ NEW(+53.4K) YoY NEW(+53.4K)	All Managers (Combined)	$431.3K	0.2% ($431.3K/$259.5M)	QoQ NEW(+$431.3K) YoY NEW(+$431.3K)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	8.9K	QoQ 0.00% (+0) YoY -55.75% (-11.3K)	All Managers (Combined)	$402.8K	0.2% ($402.8K/$259.5M)	QoQ +8.94% (+$33.1K) YoY -20.64% (-$104.8K)
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	75.3K	QoQ 0.00% (-0) YoY NEW(+75.3K)	All Managers (Combined)	$399.8K	0.2% ($399.8K/$259.5M)	QoQ -54.99% (-$488.6K) YoY NEW(+$399.8K)
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	33.3K	QoQ 0.00% (+0) YoY +4.49% (+1.4K)	All Managers (Combined)	$384.3K	0.1% ($384.3K/$259.5M)	QoQ +36.24% (+$102.2K) YoY +1.67% (+$6.3K)
Pharvaris N.V.(PHVScusipN69605108)	22.8K	QoQ 0.00% (-0) YoY +35.92% (-6.0K)	All Managers (Combined)	$357.5K	0.1% ($357.5K/$259.5M)	QoQ -18.10% (-$79.0K) YoY -7.65% (-$29.6K)
Xencor Inc(XNCRcusip98401F105)	31.9K	QoQ 0.00% (-0) YoY NEW(+31.9K)	All Managers (Combined)	$339.9K	0.1% ($339.9K/$259.5M)	QoQ -53.69% (-$394.2K) YoY NEW(+$339.9K)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	5.2K	QoQ NEW(+5.2K) YoY NEW(+5.2K)	All Managers (Combined)	$332.6K	0.1% ($332.6K/$259.5M)	QoQ NEW(+$332.6K) YoY NEW(+$332.6K)
Disc Medicine, Inc.(IRONcusip254604101)	6.5K	QoQ 0.00% (-0) YoY NEW(+6.5K)	All Managers (Combined)	$320.6K	0.1% ($320.6K/$259.5M)	QoQ -21.70% (-$88.9K) YoY NEW(+$320.6K)
Abivax S.A.(ABVXcusip00370M103)	49.1K	QoQ 0.00% (-0) YoY -15.05% (-8.7K)	All Managers (Combined)	$306.6K	0.1% ($306.6K/$259.5M)	QoQ -14.61% (-$52.5K) YoY -62.87% (-$519.3K)
Structure Therapeutics Inc.(GPCRcusip86366E106)	17.6K	QoQ 0.00% (-0) YoY -53.10% (-19.9K)	All Managers (Combined)	$304.0K	0.1% ($304.0K/$259.5M)	QoQ -36.17% (-$172.3K) YoY -81.05% (-$1.3M)
Perspective Therapeutics, Inc.(CATXcusip46489V302)	138.3K	QoQ 0.00% (-0) YoY NEW(+138.3K)	All Managers (Combined)	$294.7K	0.1% ($294.7K/$259.5M)	QoQ -33.22% (-$146.7K) YoY NEW(+$294.7K)